Supplementary Table S2: Clinical trials in myeloma using MRD assessments from The Role of Minimal Residual Disease Testing in Myeloma Treatment Selection and Drug Development: Current Value and Future Applications

Autor: Elena Zamagni, Nancy Valente, A. Kate Sasser, Michael D. Robbins, Gregory H. Reaman, Trevor J. Pugh, James L. Omel, Lata Mukundan, Jens G. Lohr, Robert D. Loberg, Richard F. Little, Ilan R. Kirsch, J. Milburn Jessup, Mohamad A. Hussein, Howard R. Higley, Steven I. Gutman, Jennifer S. Dickey, Alessandra Di Bacco, Faith E. Davies, Michele Cavo, Nikhil C. Munshi, Ola Landgren, Shaji K. Kumar, Nicole J. Gormley, Ann T. Farrell, Hervé Avet-Loiseau, Caroline C. Sigman, Gary J. Kelloff, Daniel Auclair, Kenneth C. Anderson
Rok vydání: 2023
Popis: Active Clinical Trials in Myeloma Using Minimal Residual Disease Assessment as Exploratory or Secondary Endpoints
Databáze: OpenAIRE